EP 27: AI Revolutionizing Drug Discovery (2023 - 2025)
The pharmaceutical industry is experiencing its most significant transformation in decades. AI is slashing drug development timelines from 10-15 years to 18-24 months and reducing costs from $2.6 billion to tens of millions—making previously impossible treatments financially feasible. Sam and Mac explore how AI is…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Inside AsembleAI: DeepTech, AI & Science
See all episodes →
EP 62: 95% of AI Pilots Fail. Here's Why | Mohamed Battisha, CTO at WEX
EP 61: "Shadow AI" — And No One's Watching | Rafi Khardalian, Actualyze AI
EP 60: Feeding the World with AI: Inside Syngenta's Data Playbook
Similar episodes from other shows
More like Inside AsembleAI: DeepTech, AI & Science →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery
How AI is saving billions of years of human research time | Max Jaderberg
AlphaFold is revolutionizing biology
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.